Karonudib is a promising anticancer therapy in hepatocellular carcinoma.

Xiangwei HuaKumar SanjivHelge GadTherese PhamCamilla GokturkAzita RastiZhenjun ZhaoKang HeMingxuan FengYunjin ZangJianjun ZhangQiang XiaThomas HelledayUlrika Warpman Berglund

Published in: Therapeutic advances in medical oncology (2019)

Altogether, these data suggest HCC relies on MTH1 for survival, which can be targeted and may open up a novel treatment option for HCC in the future.

Keyphrases

minimally invasive
electronic health record
big data
current status
cancer therapy
machine learning
combination therapy
mesenchymal stem cells
bone marrow
artificial intelligence